Please use this identifier to cite or link to this item:
http://doi.org/10.25358/openscience-7141
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xia, Ning | - |
dc.contributor.author | Förstermann, Ulrich | - |
dc.contributor.author | Li, Huige | - |
dc.date.accessioned | 2022-06-14T07:29:40Z | - |
dc.date.available | 2022-06-14T07:29:40Z | - |
dc.date.issued | 2014 | |
dc.identifier.uri | https://openscience.ub.uni-mainz.de/handle/20.500.12030/7155 | - |
dc.description.abstract | Nitric oxide (NO) derived from the endothelial NO synthase (eNOS) has antihypertensive, antithrombotic, anti-atherosclerotic and antiobesogenic properties. Resveratrol is a polyphenol phytoalexin with multiple cardiovascular and metabolic effects. Part of the beneficial effects of resveratrol are mediated by eNOS. Resveratrol stimulates NO production from eNOS by a number of mechanisms, including upregulation of eNOS expression, stimulation of eNOS enzymatic activity and reversal of eNOS uncoupling. In addition, by reducing oxidative stress, resveratrol prevents oxidative NO inactivation by superoxide thereby enhancing NO bioavailability. Molecular pathways underlying these effects of resveratrol involve SIRT1, AMPK, Nrf2 and estrogen receptors. | de_DE |
dc.description.sponsorship | DFG, Open Access-Publizieren Universität Mainz / Universitätsmedizin | de |
dc.language.iso | eng | de |
dc.rights | CC BY | * |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.ddc | 610 Medizin | de_DE |
dc.subject.ddc | 610 Medical sciences | en_GB |
dc.title | Resveratrol and endothelial nitric oxide | de_DE |
dc.type | Zeitschriftenaufsatz | de |
dc.identifier.doi | http://doi.org/10.25358/openscience-7141 | - |
jgu.type.contenttype | Review | de |
jgu.type.dinitype | article | en_GB |
jgu.type.version | Published version | de |
jgu.type.resource | Text | de |
jgu.organisation.department | FB 04 Medizin | de |
jgu.organisation.number | 2700 | - |
jgu.organisation.name | Johannes Gutenberg-Universität Mainz | - |
jgu.rights.accessrights | openAccess | - |
jgu.journal.title | Molecules | de |
jgu.journal.volume | 19 | de |
jgu.journal.issue | 10 | de |
jgu.pages.start | 16102 | de |
jgu.pages.end | 16121 | de |
jgu.publisher.year | 2014 | - |
jgu.publisher.name | MDPI | de |
jgu.publisher.place | Basel | de |
jgu.publisher.uri | http://dx.doi.org/10.3390/molecules191016102 | de |
jgu.publisher.issn | 1420-3049 | de |
jgu.organisation.place | Mainz | - |
jgu.subject.ddccode | 610 | de |
opus.date.modified | 2018-08-09T08:24:09Z | |
opus.subject.dfgcode | 04-205 | |
opus.organisation.string | FB 04: Medizin: Institut für Pharmakologie | de_DE |
opus.identifier.opusid | 27362 | |
opus.institute.number | 0413 | |
opus.metadataonly | false | |
opus.type.contenttype | Übersichtsartikel | de_DE |
opus.type.contenttype | Review Article | en_EN |
opus.affiliated | Xia, Ning | |
opus.affiliated | Förstermann, Ulrich | |
opus.affiliated | Li, Huige | |
jgu.publisher.doi | 10.3390/molecules191016102 | de |
jgu.organisation.ror | https://ror.org/023b0x485 | |
Appears in collections: | DFG-OA-Publizieren (2012 - 2017) |
Files in This Item:
File | Description | Size | Format | ||
---|---|---|---|---|---|
resveratrol_and_endothelial_n-20220614092201451.pdf | 959.49 kB | Adobe PDF | View/Open |